<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0235139.ref053">
 <label>53</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Kaul</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>McGeer</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Norrby-Teglund</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Kotb</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Schwartz</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>O'Rourke</surname>
   <given-names>K</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome—a comparative observational study. The Canadian Streptococcal Study Group</article-title>. 
  <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>. 
  <year>1999</year>;
  <volume>28</volume>(
  <issue>4</issue>):
  <fpage>800</fpage>–
  <lpage>7</lpage>. Epub 2000/05/29. 
  <pub-id pub-id-type="doi">10.1086/515199</pub-id> .
  <?supplied-pmid 10825042?>
  <pub-id pub-id-type="pmid">10825042</pub-id>
 </mixed-citation>
</ref>
